Association between Synapsin III gene promoter polymorphisms and multiple sclerosis

Journal of Neurology

Volumn 251, Issue 2, 2004, Pages 165-170

  Liguori, Maria ^a   Cittadella, Rita ^a   Manna, Ida ^a   Valentino, Paola ^c   La Russa, Antonella ^a   Serra, Paolo ^a   Trojano, Maria ^b   Messina, Demetrio ^a   Ruscica, Francesca ^c   Andreoli, Virginia ^a   Romeo, Nelide ^a   Livrea, Paolo ^b   Quattrone, Aldo ^a,c  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Association study; Linkage disequilibrium; Multiple sclerosis; SYN3 polymorphism; Synapsins

Indexed keywords

SYNAPSIN II;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HAPLOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN FUNCTION; SEQUENCE ANALYSIS;

ADOLESCENT; ADULT; AGED; AXONS; CHILD; CHROMOSOMES, HUMAN, PAIR 22; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HAPLOTYPES; HUMANS; ITALY; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUTATION; NERVE DEGENERATION; NEUROPEPTIDES; PHOSPHOPROTEINS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 10744221344     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-004-0293-7     Document Type: Article

References (28)

1. Compston A, Sawcer S (2002) Genetic analysis of multiple sclerosis (Review). Curr Neurol Neurosci Rep 2(3): 259-266
2. Brod SA, Benjamin D, Hafler DA (1991) Restricted T cell expression of IL2/IFNg mRNA in human inflammatory disease. J Immunol 147:810-815
3. D'Alfonso S, Nistico L, Zavattari P, Marrosu MG, Murru R, Lai M, Massacesi L, Ballerini C, Gestri D, Salvetti M, Ristori G, Bomprezzi R, Trojano M, Liguori M, Gambi D, Quattrone A, Fruci D, Cucca F, Richiardi PM, Tosi R (1999) Linkage analysis of Multiple Sclerosis with candidate region markers in Sardinian and Continental Italian families. Eur J Hum Genet 7: 177-185
4. De Santis ML, Roth GA, Cumar FA (1992) Cellular immune crossreactivity between myelin basic protein and synapsin in rats with experimental allergic encephalomyelitis. J Neurosci Res 31:46-51
5. Ferreira A, Kao HT, Feng J, Rapoport M, Greengard P (2000) Synapsin III: developmental expression, subcellular localization and role in axon formation. J Neurosci 20(10):3736-3744
6. Filippi M, Bozzali M, Rovaris M, Gonen O, Kesavadas C, Ghezzi A, Martinelli V, Grossman RI, Scotti G, Falini A (2003) Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 126:433-437
7. Hilfiker S, Pieribone VA, Czernik AJ, Kao H-T, Augustine GJ, Greengard P (1999) Synapsins as regulators of neurotransmitter release. Philos Trans R Soc Lond B Biol Sci 354:269-279
8. Jovanovic JN, Benfenati F, Siow YL, Sihra TS, Sanghera JS, Pelech SL, Greengard P, Czernik AJ (1996) Neurotrophins stimulate phosphorylation of synapsin I by MAP kinase and regulate synapsin I-actin interactions. Proc Natl Acad Sci USA, pp 3679-3683
9. Kantarci OH, de Andrade M, Weinshenker BG (2002) Identifying disease modifying genes in multiple sclerosis. J Neuroimmunol 123(1-2):144-159
10. Kao HT, Porton B, Czernik J, Feng J, Yiu G, Haring M, Benfenati F, Greengard P (1998) A third member of the synapsin gene family. Proc Natl Acad Sci USA 95:4667-4672
11. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444-1452
12. Lewontin RC (1964) The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 49:49-67
13. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46(4):907-911
14. Mc Donald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50: 121-127
15. Nicot A, Ratnakar PV, Ron Y, Chen C-C, Elkabes S (2003) Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction. Brain 126: 398-412
16. Ohmori O, Shinkai T, Hori H, Kojima H, Nakamura J (2000) Synapsin III gene polymorphisms and schizophrenia. Neurosci Lett 279:125-127
17. Olsson T (1993) Cytokines in neuroinflammatory disease: role of myelin-autoreactive T cell production of interferon-gamma. J Neuroimmunol 40: 211-218
18. Pedraza LT, Roth GA, Cumar FA (1988) Identification as synapsin of a synaptosomal protein immunoreacting with anti-myelin basic protein serum. J Neurochem 51:413-420
19. Pette M, Pette DF, Muraro PA, Farnon E, Martin R, McFarland HF (1997) Interferon-beta interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes. Neurology 49:385-392
20. Polak T, Schlaf G, Scholl U, Krome-Cesar C, Mader M, Felgenhauer K, Weber F (2001) Characterization of the human T cell response against the neuronal protein synapsin in patients with multiple sclerosis. J Neuroimmunol 115:176-181
21. Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Luer W, Helwig A, Poser S (1995) Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 37(1):82-88
22. Sudhof TC, Czernik AJ, Kao HT, Takei K, Johnston PA, Horiuchi A, Kanazir SD, Wagner MA, Perin MS, De Camilli P, Greengard P (1989) Synapsins: mosaics of shared and individual domains in a family of synaptic vesicle phosphoproteins. Science 245(4925): 1474-1480
23. st ed): Baltimore 1994, pp 188-198
24. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285
25. Tsai M, Hung C, Tsai C, Liu MY, Su YC, Chen YH, Hsiao KJ, Chen CH (2002) Mutation analysis of synapsin III gene in schizophrenia. Am J Med Genet 114:79-83
26. Van der Veen RC, Stohlman SA (1993) Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J Neuroimmunol 48(2):213-220
27. Waxman SG (2000) Multiple sclerosis as a neuronal disease. Arch Neurol 57:22-24
28. Weber F, Polak T, Gunther A, Kubuschok B, Janovskaja J, Bitsch A, Poser S, Rieckmann P (1998) Synergistic immunomodulatory effects of interferon-β1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing remitting multiple sclerosis. Ann Neurol 44:27-34